Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Assets
Cash and due from banks	$ 4,624	$ 12,716
Interest earning deposits with banks	216,903	167,660
Cash and cash equivalents	221,527	180,376
Investment securities available for sale, at fair value	5,551	7,095
Investment securities held to maturity, net of allowance for credit losses of $0 at December 31, 2024 and 2023 (fair value of $7,492 at December 31, 2024 and $7,892 at December 31, 2023)	9,209	9,292
Total investment securities	14,760	16,387
Loans, net of unearned income	1,868,153	1,787,340
Less: Allowance for credit losses	(32,573)	(32,131)
Net loans	1,835,580	1,755,209
Accrued interest receivable	9,659	8,555
Premises and equipment, net	5,316	5,579
Restricted stock	8,619	7,636
Bank owned life insurance (BOLI)	29,070	28,415
Deferred tax asset	9,113	9,262
Other real estate owned (OREO)	1,562	1,550
Other assets	7,030	10,531
Total Assets	2,142,236	2,023,500
Deposits
Noninterest-bearing deposits	184,037	232,189
Interest-bearing deposits	1,447,013	1,320,638
Total deposits	1,631,050	1,552,827
FHLBNY borrowings	145,000	125,000
Subordinated debentures	43,300	43,111
Accrued interest payable	7,968	4,146
Accrued expenses and other liabilities	14,845	14,099
Total liabilities	1,842,163	1,739,183
Shareholders' Equity
Preferred stock, 1,000,000 shares authorized, $1,000 liquidation value Series B non-cumulative convertible; 325 shares and 375 shares outstanding at December 31, 2024 and 2023, respectively	325	375
Common stock, $0.10 par value; authorized 15,000,000 shares; Issued: 12,313,489 shares and 12,240,821 shares at December 31, 2024 and 2023, respectively	1,231	1,224
Additional paid-in capital	137,784	136,700
Retained earnings	168,347	149,437
Accumulated other comprehensive loss	(337)	(404)
Treasury stock, 484,522 shares and 284,522 shares at December 31, 2024 and 2023, respectively, at cost	(7,277)	(3,015)
Total shareholders’ equity	300,073	284,317
Total liabilities and shareholders' equity	$ 2,142,236	$ 2,023,500